Table 2.

Average normotensive and DOCA–salt-treated baseline values (mean ± SEM) for Agtr1a-ChR2 (n = 7–11) and Agtr1a-Cre (n = 8–13) mice

	Normotensive		DOCA–salt
	Agtr1a-ChR2	Agtr1a-Cre	Agtr1a-ChR2	Agtr1a-Cre
SBP (mmHg)	100.61 ± 1.27	104.37 ± 2.09	114.86 ± 2.64*	119.75 ± 1.05*
DBP (mmHg)	74.61 ± 1.42	77.93 ± 2.25	86.33 ± 1.42*	90.18 ± 1.86*
MAP (mmHg)	88.08 ± 1.19	91.10 ± 2.40	100.62 ± 2.38*	104.30 ± 1.34*
HR (bpm)	453.67 ± 11.64	474.69 ± 8.36	417.53 ± 10.14*	407.55 ± 6.22*

There was a significant effect of DOCA–salt treatment for SBP (F_(1,13) = 56.71, p < 0.0001), DBP (F_(1,13) = 62.29, p < 0.0001), MAP (F_(1,13) = 60.56, p < 0.0001), and HR (F_(1,13) = 54.95, p < 0.0001); two-way RM ANOVA followed by Bonferroni's multiple-comparisons test.

^*Significantly different from within group normotensive value (p < 0.05).